Cancer Biology Meeting: “Dissecting the Role of KEAP1 Pathway in Mediating Therapeutic Sensitivity in EGFR- Driven Lung Adenocarcinoma” and “A Hypoxia-Driven Transcriptional Program Characterizes Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer”